cGxP.wire https://validator.w3.org/feed/docs/rss2.html Rhythm Publishes Phase 3 IMCIVREE Data in NEJM GeneCentric Launches ExpressCT Rewind to Unlock Gene Expression from Liquid Biopsy Data Ipsen Reports Positive Phase III Dysport Migraine Results Roche Receives CE Mark for Elecsys IGRA TB Test Johnson & Johnson Wins FDA Approval for Dual Energy Platform iHealthScreen Wins FDA 510(k) for iPredict-DR Software Sino Biopharm Secures $2.1B TQC3721 AstraZeneca Agreement Immunome NDA for Varegacestat Accepted by FDA for DTs Biocytogen Partners Whitehawk on BsADC Cancer Therapies Vera Therapeutics Wins FDA Approval for TRUTAKNA in IgAN Akston Reports Positive Canine Osteoarthritis Study Results Penumbra Enrolls First Patient in FORWARD Stroke Study FibroBiologics Advances CYWC628 DFU Trial Manufacturing Nyra Medical Enrolls First Patient in ENHANCE EFS Trial Arcutis FDA Accepts ZORYVE sNDA for Infant Dermatitis UroGen Announces FDA Clearance of IND for UGN-501 in Bladder Cancer Francis Medical Achieves California Vanquish Milestone 60 Degrees Pharma Expands Tick-Borne Disease Pipeline Genespire Reports Durable Preclinical Gene Therapy Results for Methylmalonic Acidemia Chemomab and Scipher Unite for AI-Powered Rheumatoid Arthritis Satellos Reports Positive Six-Month SAT-3247 Data Acumen to Present Alzheimer’s Research at AAIC 2026 PreludeDx Expands DCIS Education Through New Collaboration Vaxart Reports Positive 12-Month Phase 2b Safety Data OKYO Pharma Receives FDA Support for Phase 3 Trial Seres Therapeutics Reports Positive Early SER-155 Data LTZ Therapeutics Receives FDA IND Clearance for LTZ-232 Nucleus Biologics Launches CRAIC Formulation Finder TaiMed Receives TFDA Notice for Trogarzo Insilico Begins Phase III Trial of AI-Designed IPF Therapy New England Biolabs Launches Direct RNA Sequencing Module Vanda Gains FDA Rare Pediatric Designation for VCA-894A WAVES Restores Emergency Veterinary Care in East Bay Revolution Medicines Advances Daraxonrasib Under EMA Review Teva Advances TEV-408 to Phase 2b for Vitiligo Praxis and Remagine Collaborate on Ulixacaltamide Alamar Biosciences Launches First Blood Test for eMTBR-Tau Evogene, Tel Aviv University Advance AI Drug Discovery OTR Therapeutics and LG Chem Partner to Advance Oncology Therapies Longeviti Launches AI-Powered Brain Ultrasound Interface BioLineRx and Hemispherian Report Promising GLIX1 Ovarian Cancer Data Grünenthal Receives Dual FDA Designations for Tegacorat in DMD Keenova Reports Positive Phase 3 Results for XIAFLEX Caristo Diagnostics Highlights AI Heart Imaging at SCCT 2026 RoosterBio and Applied StemCell Partner to Scale iPSC Manufacturing Aligos Secures $25M Upfront in Greater China Deal Angelini Ventures Invests in Handspring Health Series B Grey Matters Receives First Brain-Dedicated PET Scanner Belite Bio Highlights DRAGON Trial at ISCEV and ASRS MindMaze Supports Stroke Recovery Combination Therapy Study